Loading...
Browse all stories on DeepNewz Dismiss →
Prediction Markets
Will the FDA approve a new immunotherapy drug for advanced melanoma by the end of 2024?
Will Merck's immunotherapy show a median overall survival of 75 months in the next trial results by end of 2024?
Will the combination therapy of nivolumab and ipilimumab be adopted as the standard of care for advanced melanoma by major cancer centers in the US by mid-2025?
What will be the median overall survival reported in the next major clinical trial results for advanced melanoma immunotherapy by end of 2024?
Which company will present the most promising immunotherapy results for advanced melanoma at the next major conference in 2025?
What will be the 5-year survival rate for advanced melanoma patients treated with combination immunotherapy by end of 2025?